Replies to post #84963 on Biotech Values

[DewDiligence]

VNDA:

I don't know why they didn't just sell themselves for say $500 million which would have been close to a 60% premium. Instead they sign a deal for $465 million.

$200M up-front and $265M in potential milestones is not $465M of NPV.